Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
516.00
Ask:
520.00
Spread: 4.00 (0.775%)
Market Cap: £860.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Statement re press speculation

17 Jan 2011 15:51

RNS Number : 6051Z
Oakley Capital Investments Limited
17 January 2011
 



 

 

17 January 2011

 

Oakley Capital Investments Limited

 

Statement re Press Speculation

 

 

Oakley Capital Investments Limited (AIM: OCL, "OCIL"), the AIM-listed company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. (the "Limited Partnership"), notes the recent press speculation concerning a potential sale of Verivox, one of the Limited Partnership's portfolio investments. OCIL can confirm that the Limited Partnership has received approaches in relation to Verivox and is in the early stages of exploring its options.

Further announcements will be made if appropriate. 

-ends-

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens (Director)

Financial Dynamics

+44 20 7831 3113

Juliet Clarke / James Macey-White

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Steven Tredget

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCEASFXFSEFEFF
Date   Source Headline
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTotal Voting Rights
25th Mar 20253:16 pmRNSTransaction in Own Shares
24th Mar 20257:00 amRNSCapital Allocation Update
13th Mar 20257:00 amRNSFinal Results for the Year Ended 31 December 2024
26th Feb 20257:00 amRNSNotice of Results and Investor Presentation
5th Feb 20257:00 amRNSDirector Dealing
5th Feb 20257:00 amRNSDirector Dealing
3rd Feb 20257:00 amRNSDirector Dealing
29th Jan 20257:00 amRNSTrading update for the year ended 31 December 2024
20th Dec 202410:49 amRNSDirector Dealing
20th Dec 202410:48 amRNSDirector Dealing
19th Dec 20247:00 amRNSNorth Sails: Conversion of Equity
13th Dec 20247:00 amRNSDirector Dealing
13th Dec 20247:00 amRNSDirector Dealing
20th Nov 20247:00 amRNSOakley Capital invests in Konzept & Marketing
11th Nov 20247:00 amRNSHolding(s) in Company
8th Nov 20244:52 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSAppointment of Non-Executive Director
24th Oct 20247:00 amRNSOakley Capital agrees sale of Schülerhilfe to LLCP
23rd Oct 20247:00 amRNSTrading update for the 3 months ended 30 Sep 2024
21st Oct 20247:00 amRNSHolding(s) in Company
7th Oct 20247:00 amRNSOakley Capital invests in Assured Data Protection
12th Sep 20247:00 amRNSInterim Results for the 6 months ended 30 June 24
2nd Sep 20247:00 amRNSOakley agrees sale of Ocean to Lloyds Register
29th Aug 20247:00 amRNSNotice of Results and Investor Presentation
13th Aug 20247:00 amRNSDirector Dealing
26th Jul 20247:00 amRNSDirector Dealing
24th Jul 20247:00 amRNSTrading Update for the 6 Months ended 30 June 2024
17th Jul 20243:52 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSOakley agrees sale of its investment in idealista
11th Jun 20247:00 amRNSOakley to invest in cybersecurity firm I-TRACING
7th Jun 20247:00 amRNSDirector Dealing
3rd Jun 20243:43 pmRNSResult of AGM
28th May 20247:00 amRNSOakley Capital invests in ProductLife Group
14th May 20247:00 amRNSOakley Capital invests in vitroconnect
8th May 20247:00 amRNSNotice of Annual General Meeting
24th Apr 20247:00 amRNSTrading Update for the 3 months ended 31 March 24
2nd Apr 20244:17 pmRNSUpdate from QuotedData
27th Mar 20247:00 amRNSDirector Dealing
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.